Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
75.17 EUR | +0.41% | +0.99% | -9.52% |
Apr. 26 | BRENNTAG : Barclays keeps a Sell rating | ZD |
Apr. 23 | Baader lowers Brenntag to 'Add' and target to 85 euros | DP |
Strengths
- The company has attractive valuation levels with a low EV/sales ratio compared with its peers.
Weaknesses
- As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
- For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
- Revenue estimates are regularly revised downwards for the current and coming years.
- For the last four months, EPS estimates made by Standard & Poor's analysts have been revised downwards.
- The average consensus view of analysts covering the stock has deteriorated over the past four months.
- Over the past twelve months, analysts' consensus has been significantly revised downwards.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Diversified Chemicals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-9.52% | 11.54B | B | ||
-0.19% | 74.89B | B | ||
+0.10% | 46.52B | A- | ||
-4.19% | 30.82B | C | ||
+11.27% | 18.19B | B | ||
+6.39% | 11.24B | A- | ||
-7.38% | 9.73B | - | ||
+2.79% | 9.4B | A- | ||
+6.33% | 9.37B | C- | ||
+3.85% | 8.11B | B |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- BNR Stock
- Ratings Brenntag SE